429 related articles for article (PubMed ID: 21986465)
1. Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxaban.
Harenberg J; Marx S; Krämer R; Giese C; Weiss C
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):637-41. PubMed ID: 21986465
[TBL] [Abstract][Full Text] [Related]
2. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
3. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
[TBL] [Abstract][Full Text] [Related]
4. An International Sensitivity Index (ISI) derived from patients with abnormal liver function improves agreement between INRs determined with different reagents.
Sermon AM; Smith JM; Maclean R; Kitchen S
Thromb Haemost; 2010 Apr; 103(4):757-65. PubMed ID: 20174759
[TBL] [Abstract][Full Text] [Related]
5. Use of INR calibrator plasmas in the routine coagulation laboratory: a study of two thrombolastin reagents.
Fattorini A; Pattarini E; Viganò S; Crippa L; D'Angelo A
Thromb Res; 2012 Sep; 130(3):e158-62. PubMed ID: 22682443
[TBL] [Abstract][Full Text] [Related]
6. A comparison of INRs after local calibration of thromboplastin international sensitivity indexes.
McGlasson DL
Clin Lab Sci; 2002; 15(2):91-5. PubMed ID: 12776770
[TBL] [Abstract][Full Text] [Related]
7. The rivaroxaban-adjusted normalized ratio: use of the prothrombin time to monitor the therapeutic effect of rivaroxaban.
Kim B; Jang S; Lee YJ; Park N; Cho YU; Park CJ
Br J Biomed Sci; 2019 Jul; 76(3):122-128. PubMed ID: 30967043
[No Abstract] [Full Text] [Related]
8. Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.
Samama MM; Martinoli JL; LeFlem L; Guinet C; Plu-Bureau G; Depasse F; Perzborn E
Thromb Haemost; 2010 Apr; 103(4):815-25. PubMed ID: 20135059
[TBL] [Abstract][Full Text] [Related]
9. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
10. Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay.
Barrett YC; Wang Z; Frost C; Shenker A
Thromb Haemost; 2010 Dec; 104(6):1263-71. PubMed ID: 20978714
[TBL] [Abstract][Full Text] [Related]
11. Influence of blood collection systems on the prothrombin time and international sensitivity index determined with human and rabbit thromboplastin reagents.
van den Besselaar AM; Hoekstra MM; Witteveen E; Didden JH; van der Meer FJ
Am J Clin Pathol; 2007 May; 127(5):724-9. PubMed ID: 17439830
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls.
Samama MM; Contant G; Spiro TE; Perzborn E; Guinet C; Gourmelin Y; Le Flem L; Rohde G; Martinoli JL;
Thromb Haemost; 2012 Feb; 107(2):379-87. PubMed ID: 22187012
[TBL] [Abstract][Full Text] [Related]
13. [Accuracy and reliability of international normalized ratio (INR) in monitoring of warfarin--comparison in the sensitivity to extrinsic coagulation factors between PT (INR) and TT (INR)].
Sakayori T; Naito S; Yoshida M; Kumano O; Kato N; Okuda M; Ieko M
Rinsho Byori; 2010 Aug; 58(8):779-85. PubMed ID: 20860170
[TBL] [Abstract][Full Text] [Related]
14. Field study of lyophilized calibrant plasmas for fresh plasma INR determination.
van den Besselaar AM; Houbouyan-Réveillard LL
Thromb Haemost; 2002 Feb; 87(2):277-81. PubMed ID: 11859852
[TBL] [Abstract][Full Text] [Related]
15. Influence of dabigatran and rivaroxaban on routine coagulation assays. A nationwide Belgian survey.
Van Blerk M; Bailleul E; Chatelain B; Demulder A; Devreese K; Douxfils J; Jochmans K; Mullier F; Wijns W; Soumali MR; Coucke W; Vernelen K; Van de Walle P
Thromb Haemost; 2015 Jan; 113(1):154-64. PubMed ID: 25231101
[TBL] [Abstract][Full Text] [Related]
16. [Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time].
Kagawa K; Fukutake K
Rinsho Byori; 1999 May; 47(5):431-7. PubMed ID: 10375964
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the use of commercial drug-specific calibrators for determining PT and APTT reagent sensitivity to dabigatran and rivaroxaban.
Gosselin RC; Adcock D; Hawes EM; Francart SJ; Grant RP; Moll S
Thromb Haemost; 2015 Jan; 113(1):77-84. PubMed ID: 25413383
[TBL] [Abstract][Full Text] [Related]
18. Local verification and assignment of mean normal prothrombin time and International Sensitivity Index values across various instruments: recent experience and outcome from North America.
Tange JI; Grill D; Koch CD; Ybabez RJ; Krekelberg BJ; Fylling KA; Wiese CR; Baumann NA; Block DR; Karon BS; Chen D; Pruthi RK
Semin Thromb Hemost; 2014 Feb; 40(1):115-20. PubMed ID: 24381152
[TBL] [Abstract][Full Text] [Related]
19. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
Horsti J
Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
[TBL] [Abstract][Full Text] [Related]
20. Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levels.
Francart SJ; Hawes EM; Deal AM; Adcock DM; Gosselin R; Jeanneret C; Friedman KD; Moll S
Thromb Haemost; 2014 Jun; 111(6):1133-40. PubMed ID: 24401946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
